"10.1371_journal.pone.0005165","plos one","2009-04-14T00:00:00Z","Caterina Guinovart; John J Aponte; Jahit Sacarlal; Pedro Aide; Amanda Leach; Quique Bassat; Eusébio Macete; Carlota Dobaño; Marc Lievens; Christian Loucq; W Ripley Ballou; Joe Cohen; Pedro L Alonso","Barcelona Centre for International Health Research, Hospital Clínic/IDIBAPS, Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde da Manhiça, Manhiça, Maputo, Mozambique; Faculdade de Medicina, Universidade Eduardo Mondlane, Maputo, Mozambique; Instituto Nacional de Saúde, Maputo, Mozambique; GlaxoSmithKline Biologicals, Rixensart, Belgium; Direcçao Nacional de Saúde, Ministério de Saúde, Maputo, Mozambique; PATH Malaria Vaccine Initiative, Bethesda, Maryland, United States of America","Conceived and designed the experiments: CG JJA CD PLA. Performed the experiments: CG JJA JS PA QB EM PLA. Analyzed the data: JJA ML. Wrote the paper: CG CD CL PLA. Contributed to the interpretation of the results and write up of the manuscript: JJA JS AL CL RB JC. Participated in the design and implementation of the original trial: JS AL RB JC.","MVI supports the development and testing of a number of malaria vaccines, including some that can be regarded as competitors. AL, ML, WRB* and JC are currently employed by GSK Biologicals or *were employed at the time the study was conducted. AL, WRB and JC hold shares in GlaxoSmithKline. JC and WRB are inventors on patents relating to malaria vaccines. None of the other authors in this paper have declared a conflict of interest.","2009","04","Caterina Guinovart","CG",13,TRUE,4,7,2,4,TRUE,FALSE,FALSE,0,NA,FALSE
